It's just that over the years I have seen examples of serious anticipatory selling ahead of what turned out to be a very positive trial result, and just the opposite, heavy buying ahead of a very negative result report.
In this case, I think the negatives resulting from the one-year delay in the oxypatch and the removal of POH from the ASX 300 are acting as an overall depressant - one which I hope will be dispelled by an oxymorphone performance that falls right into line with expectations, demonstrating that the company has the technology locked down.
- Forums
- ASX - By Stock
- AVE
- so when is this news due?
so when is this news due?, page-36
Featured News
Add AVE (ASX) to my watchlist
|
|||||
Last
0.3¢ |
Change
0.001(20.0%) |
Mkt cap ! $9.507M |
Open | High | Low | Value | Volume |
0.3¢ | 0.3¢ | 0.3¢ | $1.366K | 455.7K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
60 | 99145902 | 0.2¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.3¢ | 22467224 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
60 | 99145902 | 0.002 |
20 | 74250508 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.003 | 22467224 | 7 |
0.004 | 24316867 | 21 |
0.005 | 27709765 | 14 |
0.006 | 19365067 | 10 |
0.007 | 9365221 | 8 |
Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
Featured News
AVE (ASX) Chart |